Search Results - Peter M. Villiger

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Dissecting the Interaction of FGF8 with Receptor FGFRL1 by Lei Zhuang, Monique Vogel, Peter M. Villiger, Beat Trueb

    Published in Biomolecules (2020-10-01)
    Get full text
    Article


  2. 2

    Identification of a MAFB mutation in a patient with multicentric carpotarsal osteolysis by Lei Zhuang, Sabine Adler, Daniel Aeberli, Peter M. Villiger, Beat Trueb

    Published in Swiss Medical Weekly (2017-10-01)
    Get full text
    Article


  3. 3

    Cyclophosphamide: As bad as its reputation? by Diana Dan, Rahel Fischer, Sabine Adler, Frauke Förger, Peter M Villiger

    Published in Swiss Medical Weekly (2014-10-01)
    Get full text
    Article


  4. 4

    Behçet’s syndrome: clinical presentation and prevalence in Switzerland by Rahel A. Villiger, Anna-Luisa Stefanski, Véronique Grobéty, Sabine Adler, Peter M. Villiger

    Published in Swiss Medical Weekly (2019-07-01)
    Get full text
    Article


  5. 5

    Diagnostic value of contrast-enhanced magnetic resonance angiography in large-vessel vasculitis by Sabine Adler, Marco Sprecher, Felix Wermelinger, Thorsten Klink, Harald M. Bonel, Peter M. Villiger

    Published in Swiss Medical Weekly (2017-02-01)
    Get full text
    Article


  6. 6

    Anti-IL-6 Receptor Treatment in Giant Cell Arteritis Patients Reduces Levels of IL-1β-Receptor Antagonist but Not IL-1β by Joana J. da Costa, Lisa Christ, Peter M. Villiger, Monique Vogel, Martin F. Bachmann

    Published in Rheumato (2024-03-01)
    Get full text
    Article


  7. 7

    Effectiveness of the Bern Ambulatory Interprofessional Rehabilitation (BAI-Reha) programme for patients with chronic musculoskeletal pain: a cohort study by Brigitte E. Gantschnig, Franziska Heigl, Colette Widmer Leu, Lukas Bütikofer, Stephan Reichenbach, Peter M. Villiger

    Published in Swiss Medical Weekly (2017-05-01)
    Get full text
    Article


  8. 8

    Use of abatacept in rheumatoid arthritis by Johannes von Kempis, Jean Dudler, Paul Hasler, Diego Kyburz, Alan Tyndall, Pascal Zufferey, Peter M. Villiger

    Published in Swiss Medical Weekly (2012-05-01)
    Get full text
    Article


  9. 9

    Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study by Christophe Schmitt, Laura Brockwell, Mylène Giraudon, Mauro Zucchetto, Lisa Christ, Bettina Bannert, Thomas Daikeler, Peter M. Villiger

    Published in Arthritis Research & Therapy (2022-06-01)
    Get full text
    Article


  10. 10

    Serum proteomics in giant cell arteritis in response to a three-day pulse of glucocorticoid followed by tocilizumab monotherapy (the GUSTO trial) by Lisa Christ, Andrea D. Gloor, Florian Kollert, Timo Gaber, Frank Buttgereit, Stephan Reichenbach, Stephan Reichenbach, Peter M. Villiger

    Published in Frontiers in Immunology (2023-05-01)
    Get full text
    Article


  11. 11

    Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in... by Johannes von Kempis, Sabine Duetsch, Nicola Reuschling, Rahel Villiger, Peter M Villiger, Florence Vallelian, Dominik J Schaer, Ruediger B Mueller

    Published in Swiss Medical Weekly (2019-03-01)
    Get full text
    Article


  12. 12

    Vision loss in patients with giant cell arteritis treated with tocilizumab by Jennifer Amsler, Iveta Kysela, Christoph Tappeiner, Luca Seitz, Lisa Christ, Godehard Scholz, Odile Stalder, Florian Kollert, Stephan Reichenbach, Peter M. Villiger

    Published in Arthritis Research & Therapy (2021-03-01)
    Get full text
    Article


  13. 13

    Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review. by Isabelle Cleynen, Peter Jüni, Geertruida E Bekkering, Eveline Nüesch, Camila T Mendes, Stefanie Schmied, Stefan Wyder, Eliane Kellen, Peter M Villiger, Paul Rutgeerts, Séverine Vermeire, Daniel Lottaz

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  14. 14

    Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop. by Gediminas Matulis, Joseph P Sanderson, Nikolai M Lissin, Maria B Asparuhova, Gopal R Bommineni, Daniel Schümperli, Richard R Schmidt, Peter M Villiger, Bent K Jakobsen, Stephan D Gadola

    Published in PLoS Biology (2010-06-01)
    Get full text
    Article


  15. 15

    A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis by Wolfgang A. Schmidt, Bhaskar Dasgupta, Jennifer Sloane, Angeliki Giannelou, Yuqing Xu, Sebastian H. Unizony, Sarah L. Mackie, Miguel A. Gonzalez-Gay, Robert Spiera, Kenneth J. Warrington, Peter M. Villiger, Michael C. Nivens, Bolanle Akinlade, Yong Lin, Frank Buttgereit, John H. Stone

    Published in Arthritis Research & Therapy (2023-10-01)
    Get full text
    Article


  16. 16

    Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial. by Mathis Komminoth, Marc Y Donath, Matthias Hepprich, Philipp Schuetz, Claudine A Blum, Beat Mueller, Jean-Luc Reny, Pauline Gosselin, Gautier Breville, Michael Brändle, Christoph Henzen, Jörg D Leuppi, Andreas D Kistler, Robert Thurnheer, Felix Beuschlein, Gottfried Rudofsky, Daniel Aeberli, Peter M Villiger, Stephan Böhm, Irina Chifu, Martin Fassnacht, Gesine Meyer, Jörg Bojunga, Marco Cattaneo, Constantin Sluka, Helga Schneider, Jonas Rutishauser, «TOASST» study group

    Published in PLoS ONE (2023-01-01)
    Get full text
    Article


Search Tools: